Will Stone
-
The military plans to start screening service members for low testosterone, and social media is overflowing with claims about testosterone therapy. But who actually needs it?
-
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.
-
Advisers to the Food and Drug Administration voted in favor of easing regulation of popular peptides. The recommendations could pave the way for specialized pharmacies to produce them in the U.S.
-
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.
-
Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding pharmacies say they should be able to make them legally to meet demand.
-
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
-
Wellness influencers often talk about fixing a broken gut microbiome. And marketers sell tests and supplements to fix your gut health. Here's what what the evidence really shows about gut health.
-
Wellness and longevity influencers are pushing a compound called NAD+. There's scientific interest in its potential, but researchers say the marketing claims have gotten ahead of the science.
-
Researchers evaluated how well an AI model could diagnose and make decisions about patient care in the ER.
-
The coalition focused on making Americans healthier is frustrated with the Trump administration's stance on environmental toxins and most recently, its support of the company that makes the pesticide.